MEINI, GENNY
 Distribuzione geografica
Continente #
NA - Nord America 2.606
EU - Europa 2.008
AS - Asia 868
SA - Sud America 104
AF - Africa 60
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 5.648
Nazione #
US - Stati Uniti d'America 2.576
GB - Regno Unito 462
RU - Federazione Russa 386
SG - Singapore 294
CN - Cina 281
IT - Italia 229
IE - Irlanda 219
DE - Germania 174
SE - Svezia 155
UA - Ucraina 135
VN - Vietnam 90
BR - Brasile 87
FR - Francia 84
FI - Finlandia 74
HK - Hong Kong 65
ZA - Sudafrica 34
IN - India 33
ES - Italia 32
KR - Corea 25
BD - Bangladesh 13
BE - Belgio 12
CA - Canada 12
NG - Nigeria 12
JP - Giappone 10
MX - Messico 9
UZ - Uzbekistan 9
NL - Olanda 8
PL - Polonia 8
AR - Argentina 7
TR - Turchia 7
LT - Lituania 6
AT - Austria 5
ID - Indonesia 5
IQ - Iraq 5
CZ - Repubblica Ceca 4
PH - Filippine 4
DO - Repubblica Dominicana 3
NP - Nepal 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BJ - Benin 2
EC - Ecuador 2
EE - Estonia 2
EG - Egitto 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
LV - Lettonia 2
MA - Marocco 2
PK - Pakistan 2
TH - Thailandia 2
TN - Tunisia 2
VE - Venezuela 2
A1 - Anonimo 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
UY - Uruguay 1
YE - Yemen 1
Totale 5.648
Città #
Southend 407
Dallas 363
Fairfield 293
Dublin 218
Chandler 195
Ashburn 190
Singapore 160
Seattle 125
Woodbridge 122
Munich 118
Jacksonville 109
Moscow 107
Cambridge 103
Wilmington 101
Ann Arbor 100
Siena 96
Santa Clara 94
Houston 92
Beijing 80
San Jose 64
Hong Kong 63
Helsinki 45
Nanjing 37
The Dalles 35
Johannesburg 34
Princeton 34
Los Angeles 30
Dong Ket 27
Council Bluffs 26
Seoul 25
Menlo Park 24
Bologna 23
Hefei 23
Málaga 23
Boardman 21
New York 21
Ho Chi Minh City 18
Lauterbourg 18
Hanoi 17
Columbus 15
San Diego 15
São Paulo 15
Nanchang 14
San Mateo 13
Abuja 12
Brussels 12
Milan 11
Orem 11
Shanghai 11
Buffalo 9
Changsha 9
Stockholm 9
Tashkent 9
Tianjin 8
Tokyo 8
Bengaluru 7
Chennai 7
Denver 7
Phoenix 7
Atlanta 6
Hebei 6
Jiaxing 6
London 6
Norwalk 6
Chicago 5
Düsseldorf 5
Manchester 5
San Francisco 5
Shenyang 5
Warsaw 5
Amsterdam 4
Dhaka 4
Falkenstein 4
Falls Church 4
Florence 4
Hangzhou 4
Jyväskylä 4
Mexico City 4
Ningbo 4
Nuremberg 4
Rome 4
Toronto 4
Vienna 4
Bangalore 3
Boston 3
Da Nang 3
Guangzhou 3
Izmir 3
Jinan 3
Kunming 3
Lancaster 3
Manila 3
Mestre 3
Montreal 3
Redondo Beach 3
Riyadh 3
Santa Fe 3
Turku 3
Venezia 3
Zhengzhou 3
Totale 4.053
Nome #
A Prognostic Model for Estimating the Time to Virologic Failure in HIV-1 Infected Patients Undergoing a New Combination Antiretroviral Therapy Regimen 615
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group 278
Changing patterns in HIV-1 non-B clade prevalence and diversity in Italy over three decades 270
Analysis of genetic and viral determinants of HBsAg levels in patients with chronic HBV infection 270
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial 257
Stability of unfrozen whole blood DNA for remote genotypic analysis of HIV-1 coreceptor tropism 253
Comparative determination of HIV-1 coreceptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping 249
Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood 248
Total cellular HIV-1 DNA decreases after switching to raltegravir-based regimens in patients with suppressed HIV-1 RNA 247
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy 240
Low-cost simultaneous detection of CCR5-delta32 and HLA-B*5701 alleles in human immunodeficiency virus type 1 infected patients by selective multiplex endpoint PCR 239
Prevalence of HIV-1 integrase mutations related to resistance to dolutegravir in raltegravir naïve and pretreated patients 238
Near Full-Length Sequence Analysis of HIV Type 1 BF Recombinants from Italy 233
Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice 223
Rilpivirine resistance and the dangerous liaisons with substitutions at position 184 among patients infected with HIV-1: analysis from a national drug-resistance database (ARCA) 215
Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy 205
Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNA 202
Naturally occurring hepatitis C virus (HCV) NS3/4A protease inhibitor resistance-related mutations in HCV genotype 1-infected subjects in Italy 197
First external quality assurance program of the Italian HLA-B*57:01 Network assessing the performance of clinical virology laboratories in HLA-B*57:01 testing 193
Impact of remote vs. local sampling on sensitivity of genotypic antiretroviral resistance testing 180
Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group 162
Frequent Detection of Antiretroviral Drug Resistance in HIV-1-Infected Orphaned Children Followed at a Donor-Funded Rural Pediatric Clinic in Dodoma, Tanzania 133
Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection 126
null 121
null 108
Totale 5.702
Categoria #
all - tutte 16.097
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.097


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021123 0 0 0 0 0 0 0 0 0 32 34 57
2021/2022313 22 40 15 51 15 11 18 16 13 31 23 58
2022/2023534 23 62 53 94 52 95 14 43 49 27 16 6
2023/2024305 14 7 19 24 3 73 125 10 0 6 4 20
2024/2025765 7 31 90 37 73 65 59 64 114 24 69 132
2025/20261.587 116 206 312 197 407 47 152 43 42 65 0 0
Totale 5.702